Velactis solution for injection for cattle
Since the market launch of "Velactis" in March 2016, serious side effects have been reported.
the Scientific Committee for Medicinal Products for Veterinary Use of the European Medicines
Veterinary Use) of the European Medicines Agency (EMA) has decided to notify the European Commission of a
a suspension of the marketing authorization and a precautionary recall of all batches on the market.
on the market.
Based on these recommendations, the marketing authorization holder "Ceva Santé Animale" is now issuing a
recall of the following batches of "Velactis", which have been placed on the market in Austria:
Velactis 1,12 mg/ml solution for injection for cattle
Batch numbers: 106A3, 107A2
Veterinarians are urged to suspend the sale and use of "Velactis
and to contact the end users (farmers) and retrieve the product from them.
to retrieve the product from them.
|Name of the medicinal product||Velactis 1,12 mg/ml Injektionslösung für Rinder|
|Marketing authorisation number(s)||EU/2/15/192/001-004|
|Marketing authorisation holder||Ceva Santé Animale|
|Batch number(s)||106A3, 107A2|